Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma

Title
Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 24, Pages eaay7973
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-06-11
DOI
10.1126/sciadv.aay7973

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started